In compliance with section 17(b) of the Securities Act, we are disclosing that Atai Life Sciences N.V. (NASDAQ: ATAI) is a client of TraDigital Marketing Group, Inc. Atai Life Sciences N.V. has an agreement in place, dated March 7, 2023 – December 21, 2023 to compensate TraDigital Marketing Group, Inc. as follows: three hundred sixty-seven thousand five hundred dollars ($367,500) for a marketing budget, plus a retainer fee of 20% of the Marketing Cost Spent which equals seventy-three thousand five hundred dollars ($73,500), for publicly disseminating information about Atai Life Sciences N.V. via website, email, and SMS. 

In compliance with section 17(b) of the Securities Act, we are disclosing that Atai Life Sciences N.V. (NASDAQ: ATAI) is a client of TraDigital Marketing Group, Inc. Atai Life Sciences N.V. has an agreement in place, dated September 25, 2023 to compensate TraDigital Marketing Group, Inc. a cash retainer of eighty-five thousand dollars ($85,000) for publicly disseminating information about Template Company via website, email, and SMS. 

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.